Crossmark

Integrated DFT, molecular docking, and molecular dynamics investigation of some novel 2-thiohydantoin analogues as potent CDK2 inhibitors for anticancer therapy

Crossref DOI link: https://doi.org/10.1038/s41598-026-42330-4

Published Online: 2026-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khaled, Nada A.

Ahmed, Sayed A.

Ibrahim, Medhat A.

Ahmed, Osama M.

Mohamed, Neama A.

Khalifa, Nagy M.
Funding

Funding for this research was provided by:

National Research Centre Egypt
License Information

Text and Data Mining valid from 2026-03-26

Version of Record valid from 2026-04-01
More Information

Article History

Received: 8 January 2026

Accepted: 25 February 2026

First Online: 26 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below